Deliver logo

About ATMP Shanghai Forum 2024

The Advanced Therapy Medicinal Products ( Shanghai ) Forum -- Global Gene & Cellular Immunotherapy Innovators Shanghai Forum 2024 will bring in fresh perspectives and establish an efficient platform for Academia & Industry to discuss about the Current and Future Perspectives of Advanced Therapy Medicinal Products ( ATMPs ), Promoting China Innovation and Strengthening Collaboration in the Advanced Therapies and Regenerative Medicine Space.

Brainstorm with over 100+ high caliber speakers and estimation to bring over 500+ Industry Stakeholders, Entrepreneurs, Cell and Gene Therapy Pioneers, Influencers and Pharma R&D professionals. With this in mind, The Themes of "Advanced Therapy Medicinal Products ( Shanghai ) Forum -- Global Gene & Cellular Immunotherapy Innovators Shanghai Forum 2024" will cover...
Learn more >>
Speaker Faculty
Danny Soon
Chief Executive Officer
Consortium for Clinical Research and Innovation, Singapore (CRIS)
Executive Director
Singapore Clinical Research Institute (SCRI)
Interim Executive Director
Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)
Zhigang Tian
Professor & Director，Institute of Immunology, School of Life Sciences and Medicine
University of Science & Technology of China
Aimin Hui
Founder, Chair and CEO
EnCureGen Pharma, Honorary Fosun Global Partner
Mitchell Ho
Senior Investigator Head, Antibody Therapy Section Deputy Chief, Laboratory of Molecular Biology Director, Antibody Engineering Program
National Cancer Institute, NIH
Tian Xu
Chief Scientific Advisor
Fosun Pharma
President
Fosun Lead
Vice President
Westlake University
Linyu Shi
Co-Founder & CSO
HuidaGene Therapeutics
Gong Chen
Founder
NeuExcell Therapeutics
Professor, Director of Brain Repair Center
GHM Institute of CNS Regeneration, Jinan University
Lyu Lulu
Chief Executive Officer
Juventas Cell Therapy
Bose Kalampanayil
Chief Technology Officer
Neurophth Therapeutics
Xinping Zhao
Chief Scientific Officer
Chinagene Technology
Ales Štrancar
Chief Executive Officer
BIA Separations
Chun Zhang
Founder
Suzhou Genehealth Biotechnology
Yanjun Zhang
R&D Director
Genmedicn Biopharma
Lei Zhang
VP, Research
Neukio Biotherapeutics
Lei Yu
Founder
Shanghai Unicar-Therapy Bio-Medicine Technology
Yuxuan Wu
Founder, Chairman and CEO
Yoltech Therapeutics
James Wang
Chief Technology Officer
Juventas Cell Therapy
Yong Zou
CMC VP
IASO Biotherapeutics
Yangbing Zhao
Chairman & CSO
UTC Therapeutics
Hongbing Zhang
Vice President, Drug Discovery
Eureka Therapeutics
Wenbo Wang
Founder & CEO
Lealing Biopharma
Penghui Zhou
Founder ＆ CTO
Guangzhou Fineimmune Biotechnology
Yi Li
Chairman and Chief Scientific Officer
TIOC Therapeutics
Yanyan Han
Chief Scientific Officer
HRYZ Biotech
Ting He
Founder and CEO
Beijing Imunopharm Technology
Xiaofei Gao
Founder
Westlake Therapeutics
Howard Fang
Chief Development Officer
Alpha Biopharma
Rui Chen
VP of R&D
Hervor Therapeutics
Zhiyuan Li
Director of Functional Biology and Cell Therapy
Biotheus
Zhao Yuan
CTO
Hillgene
Chelsie He
Founder and CEO
Suzhou GenAssist
Jingmin Zhou
CEO & Co-Founder
Genemagic Biosciences
Yijie Ma
Senior Director, Head of Business Development - Strategic Partnerships
CANbridge Pharmaceuticals
Riguo Fang
Vice President of R&D
EdiGene
Ruhong Jiang
CEO
ASC Therapeutics
Ji Zhang
Co-Founder and COO
Start Bioservices
Yun Jiang
Executive Vice General Manager
LotusLake BioMedical
Adam Zhao
Chairman
Anlong Bio
Biliang Hu
CSO
Truking Gene
Cui Xinhui
Application manager
SONY (China) Life Science Business Division
Bin Li
Yu He Scholar, Distinguished Professor
SJTU
Hanming Wang
Vice President
Binhui Bio
Haifa Shen
Chief Technology Officer
StemiRNA Therapeutics
Frank Hu
Chairman and CEO
Starna Therapeutics
Ping Ding
Chairman and CEO
Cunde
Huashun Li
Chairman
Ascle Therapeutics
Peter He
Co-Founder and CTO
OriCell Therapeutics
James Pan
Chief Executive Officer
BriSTAR Immunotech
Xiaoning Guo
Chief Medical Officer
Neurophth Therapeutics
Nova Liu
General Manager
Refreshgene Therapeutics
Ke Huang
Chairman and CEO
Genocury
Peggy Lu
Medical Executive President
Lu Daopei Hospital
Jiangtao Ren
Chief Scientific Officer
BioHeng Biotech
Yongzhong Wang
Founder, Chairman and CEO
Accuredit Therapeutics
HUAQIONG SHEN
CEO & Founder
NeuShen Terapeutics
Yi Jin
Chief Executive Officer
GeCell Therapeutics
Weili Zhao
Vice President & Professor of Hematology，First Deputy Director of Shanghai Institute of Hematology
Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine
He Huang
President
The first Affiliated Hospital, School of Medicine, Zhejiang University
Yuling Li
Co-Founder and CEO
Innoforce Pharmaceuticals
Mingyao Liu
Founder, Chairman and Chief Scientist
BRL Medicine
Amy Que
CEO
Ascle Therapeutics
Richard Wang
Founder, Chairman and CEO
Neukio Biotherapeutics
Xuan Yao
Founder and CEO
HUIGENE Therapeutics
Dongqin Liu
PDS Manager
Pall Corporation
Jin Yi
Product Manager
Cytiva
Junhui Li
VP
CoJourney Biotech
Xijie Wang
Head of Technology Innovation Center（TIC）, Senior Director, Toxicology BU
Shanghai InnoStar Biotechnology
Chaohui Dai
General Manager
Shanghai HyaMab Biotech
Ke Zhang
Chief Scientific Officer
SCG Cell Therapy
Wen Wang
Chief Executive Officer
IASO Biotherapeutics
Tony Zhang
Chairman of the Board, President
Wuhan Bio-Raid Biotech
Yuchun Gu
Chief Scientist and CEO
Allife Medicine
Andy Yuan
CAR-NK Discovery Head
Innovent Cells Pharmaceutical (Suzhou)
Chijian Zuo
Chief Scientific Officer
Suzhou CureMed Biopharma Technology
Yi Feng
Senior Vice President of Medical Affairs
Juventas Cell Therapy
Lin Yang
Founder and CEO
PersonGen BioTherapeutics
Susan Mou
Chief Executive Officer
CorrectSequence Therapeutics
Yan Sun
Co-Founder and Group COO
Shanghai Cell Therapy Group
Yarong Liu
Founder and CEO
Grit Therapeutics
Cecilia Zhang
Chief Scientific Officer
Biosyngen
Crystal Sun
Founder and CEO
Immunofoco
Yu Zhang
CEO
VCANPHARMA
Jim Lu
Co-Founder and Chief Scientific Officer
TriArm Therapeutic
Jimin Gao
Professor
Wenzhou Medical University
Michael Wang
CEO and Founder
CorrGene Biotechnology
Jie Chen
Chief Medical Officer
Bioheng Biotech
Alex Chang
Founder
Shanghai YaKe Biotechnology
Changfeng Zhang
Regulatory Affairs Director
Shanghai Pharmaceuticals Holding
Xingwang Xie
Founder & Chief Executive Officer
Corregene Biotechnology
Enxiu Wang
Founder
Nanjing CART Medical
Tianhong Xu
Founder & CEO
Base Therapeutics
Xiaoyun Shang
Chief Executive Officer
Suzhou T-Maximum Bio-tech
George Zhou
CEO
Joint Biosciences
Patrick Liu
President
Cure Genetics
Qilai Cao
Head of Gene Therapy Product
Accurant BioTechnology
Fangfang Zhu
Founder & CEO
HemaCell Therapeutics
段会敏
产业发展部负责人/招商总监
星北集团•自贸壹号
Ting Zhang
Chief Executive Officer
Regend
李明明
亚洲项目合作负责人
Cytiva
Zhao Zhu
Co-Founder and CEO
Neuregen Therapeutics
Biao Dong
Co-Founder and Chief Executive Officer
Sichuan Real & Best Biotech
Andrew Lin
Founder & CEO
Lingyi Biotech
Zhijian Cai
Professor
Zhejiang University
Shi Hu
Associate Professor, School of Basic Medicine
Naval Medical University
潘轶
研发总监
序祯达生物
龙钢
病原生物系教授
复旦大学基础医学院
Previous Speaker Faculty ( ATMP/CGT 2022 ）
Carl H. June
Richard W. Vague Professor, Immunotherapy Director, Center for Cellular Immunotherapies Director, Parker Institute for Cancer Immunotherapy
University of Pennsylvania; Perelman School of Medicine
Dan Kaufman
Professor, Dept. of Medicine, Director of Cell Therapy Program
University of California San Diego Health
Chief Scientific Officer
Shoreline Biosciences
Michael Milone
Associate Professor of Pathology and Laboratory Medicine
Perelman School of Medicine, University of Pennsylvania.
Rafal Krol
Principal Investigator, Research and Development Center
Kyoto University, CiRA Foundation
Youhai Chen
Chair Professor, Dean of Faculty of Pharmaceutical Sciences
Shenzhen Institute of Advanced Technology
Sean Fu
Co-Founder and CEO
RVAC Medicines
Shanshan Wang
Senior Scientist, Process Development
Innoforce Pharmaceuticals
Lili Wang
Research Director, Translational Research and Gene Editing
Research Associate Professor, Department of Medicine
Translational Research, Gene Therapy Program
Perelman School of Medicine, University of Pennsylvania
Huimin Helen Tao
Principal Scientist, Analytical Development
Novartis Gene Therapies
Dongqin Liu
PDS Manager
Pall Corporation
Jiesi Wang
PLXF Technical Support
Agilent Technologies
Markus Haindl
Global Head Gene Therapy Technical Development, Pharma Technical Operations Cell and Gene Therapy
Roche
Bose Kalampanayil
Chief Technology Officer
Neurophth Therapeutics
Gong Chen
Founder
NeuExcell Therapeutics
Professor, Director of Brain Repair Center
GHM Institute of CNS Regeneration, Jinan University
Jose-Carlos Segovia
Co-Founder and CSO
WuXi CorrGene
Xiaoyan Dong
Co-Founder and CEO
Fiveplus and GeneCradle
Zengmin Du
Senior Director，Process R&D
Belief Biomed
Jørn Remi Henriksen
Field Application Manager
ArcticZymes Technologies ASA
Nova(Xinxing) Liu
General Manager
Shanghai Refreshgene Therapeutics
Rolf G. Werner
Professor, Industrial Biotechnology
University of Tubingen
Claire G Zhang
Chief Technology Officer
Innostellar Biotherapeutics
Jay ( Ji-Ye ) Wei
Chairman and CEO
ViewGene Therapeutics
Bin Xiang
Founder and CEO
CommBio Therapeutics
Richard Wang
Founder, Chairman and Chief Executive Officer
Neukio Biotherapeutics
Yuchun Gu
Founder and CSO
Allife Medicine
Shi-Jiang (John) Lu
President and CEO
HebeCell Corporation
Josh Wang
Product Manager
Miltenyi Biotec ( China )
Dong Wei
Chief Executive Officer
EdiGene
Patrick Liu
Co-Founder and President
CureGenetics
Biao Zheng
Chief Executive Officer
BRL Medicine
Wei Xu
Chief Scientific Officer
Innovent Cells
Jie Chen
Chief Medical Officer
Bioheng Biotech
Lijie Wu
Head of CGT Platform
PPC
Vivian Gu
Chief Medical Officer
PPC
Tony (Bizuo) Liu
Chief Executive Officer, Chief Financial Officer
Cellular Biomedicine Group
Wen Wang
Chief Executive Officer
IASO Biotherapeutics
Lin Yang
Founder and Chairman
PersonGen BioTherapeutics
Grace Zhou
Chief Executive Officer
ImmVira Group Company
Adam Zhao
Chairman
Anlong Bio
Yi Jin
Chief Scientific Officer
Genbase Biotechnology
Xiaoyun Shang
Chief Executive Officer
Suzhou T-Maximum Bio-tech
Fangfang Zhu
Founder & CEO
HemaCell Therapeutics
Yu Zhang
SVP & CSO
VCANBIO Cell & Gene Engineering
Li Zhou
Chief Scientific Officer
Juventas Cell Therapy
Alex H. Chang
Founder & CEO
Yake Biotechnology
Tianhong Xu
Founder & CEO
Base Therapeutics
Zhongwei Xu
Founder and CSO
Biocelltech Therapeutics
Zhenwei Miao
President and Chief Executive Officer
Imbioray (Hangzhou) Biomedicine
Changfeng Zhang
Regulatory Affairs Director
Shanghai Pharmaceuticals Holding
Xueqiang Zhao
CEO & Co-Founder
China Immunotech
Xingwang Xie
Founder & Chief Executive Officer
Corregene Biotechnology
Lai Wei
Chief Scientific Officer
MingMed Biotech
Ming Sun
R&D Director
Nanjing Kati Medical Technology
Wei Zuo
Founder and Chairman
Regend Therapeutics
Jim Lu
Co-Founder and Chief Scientific Officer
TriArm Therapeutic
Huashun Li
Founder and CEO
Asclepius Technology Company Group
Emily Li-Chuan Tan
Executive Vice President & Chief Operating Officer
Bennu Biotherapeutics
Yijia Li
Founder and CEO
Zinbio
Fenglan Wu
President & Co-Founder
Gritgen Therapeutics
Lianjun Shen
SVP, Head of R&D
Gracell Biotechnologies
Zefeng Wang
Professor
Shanghai Institute for Nutrition and Health, Chinese Academy of Sciences (CAS)
Sheila Yang
Executive Director, GMP Operation
Forecyte Bio
段会敏
产业发展部负责人/招商总监
星北集团•自贸壹号
蒋云
常务副总经理
清华工研院细胞与基因治疗创新中心
左炽健
首席科学家
科锐迈德生物
杭宇
递送平台技术负责人
斯微生物
APRDL2021
Supporters
Connect via Wechat
Previous Sponsors
Media Partners
ATMP Shanghai Forum 2024  |  Telephone: +86 21 6157 7321  |  E-mail: kevin.tan@deliver-consulting.com
©ATMP Shanghai Forum 2024- All rights reserved